The global custom antibody market was valued at USD 147.6 million in 2022 and is projected to reach USD 301.7 million by 2030, expanding at a CAGR of 9.7% from 2023 to 2030. This growth is largely driven by the rising demand for personalized diagnostic and therapeutic treatments, which has encouraged key market players to invest in new product development, advanced service offerings, and...